Rapport Therapeutics, Inc. (RAPP)

NASDAQ: RAPP · Real-Time Price · USD

30.81

+1.05 (3.53%)

Feb 23, 2026, 9:38 AM EST - Market open

Rapport Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Feb '26 Feb 23, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Capitalization	1,468	649	-	-
Enterprise Value	917	330	-	-
Last Close Price	29.76	17.74	-	-
PB Ratio	2.77	2.12	-	-
P/TBV Ratio	2.77	2.12	-	-
Debt / Equity Ratio	0.02	0.01	0.05	0.54
Net Debt / Equity Ratio	-0.98	-0.99	-1.00	-1.06
Net Debt / EBITDA Ratio	4.59	3.70	3.91	3.55
Net Debt / FCF Ratio	6.43	4.52	4.90	5.39
Quick Ratio	35.84	34.82	16.75	18.74
Current Ratio	36.37	35.34	17.14	18.80
Return on Equity (ROE)	-23.41%	-35.09%	-43.36%	-
Return on Assets (ROA)	-15.88%	-22.07%	-24.18%	-
Return on Capital Employed (ROCE)	-21.10%	-27.10%	-24.70%	-19.60%
Earnings Yield	-6.89%	-12.07%	-	-
FCF Yield	-5.49%	-10.36%	-	-
Buyback Yield / Dilution	-190.80%	-1277.25%	-93.74%	-

Updated Nov 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q